Table 2 Subgroup analysis on the years of study and Methods of diagnosis of metabolic syndrome
| Â | Time range | Number of articles | Sample size | I2 | Begg and Mazumdar | Prevalence (95% CI) |
|---|---|---|---|---|---|---|
Year of studies | 2005–2010 | 16 | 36,243 | 99.6 | 0.102 | 37.6 (95% CI: 28.5–47.6) |
2011–2015 | 8 | 7571 | 99.3 | 0.379 | 21.7 (95% CI: 13.2–47.1) | |
2016–2020 | 3 | 921 | 79.3 | 0.783 | 55.3 (95% CI: 47.9–62.3) | |
Methods of diagnosis of metabolic syndrome | ATPIII | 19 | 29,739 | 99.5 | 0.528 | 30.9 (95% CI: 21.3–42.3) |
WHO | 3 | 6701 | 99.4 | 0.296 | 35.7 (95% CI: 18.1–58.2) | |
IDF | 5 | 7295 | 98.3 | 0.806 | 48 (95% CI: 36.5–59.8) |